Operon Biotechnologies, Inc. To Provide Pre-Printed Microarrays (OpArrays(TM)) With AROS(TM) Content
Published: Mar 21, 2006
HUNTSVILLE, Ala., March 21 /PRNewswire/ -- Today, Operon Biotechnologies announced the availability of new OpArrays, their pre-printed microarrays for the Human, Mouse (Mus musculus), Rat (Rattus novegicus), and Arabidopsis thaliana genomes.
Utilizing its strong core business in the design and synthesis of Array Ready Oligo Sets (AROS(TM)) utilized by research labs to print their own expression arrays, Operon Biotechnologies brings to the competitive gene expression market a ready-to-use microarray with proven content and unsurpassed quality. The OpArray product line will quickly expand to include microarrays for all of the 40+ genomes currently offered through the AROS(TM) product line.
"Although the microarray field is already well populated, Operon is now able to offer its unique microarray content in the form of the well-proven AROS probes. Potential customers have requested access to AROS content through pre-printed microarrays. Now, all the requirements for new Operon products have come together with the OpArrays, an easily utilized microarray format that we can offer at highly competitive pricing," stated CEO Patrick Weiss. "We very pleased by the early response to this product and have received several customer reports confirming OpArrays offer excellent sensitivity and reproducibility. We look forward to an exciting future for Operon with this product."
About Operon Biotechnologies
Operon Biotechnologies, Inc. is a global market leader in high volume synthesis and provider of a wide range of quality DNA oligonucleotides and Array-Ready Oligo Sets (AROS(TM)). Driven by incomparable customer service and reliable delivery, Operon employs advanced synthesis technologies and consistently pursues unique innovations to maintain the highest level of excellence in both products and support. For more information, visit http://www.operon.com.Operon Biotechnologies, Inc.
CONTACT: Donna Brown of Operon Biotechnologies, Inc., +1-256-704-8190, firstname.lastname@example.org
Web site: http://www.operon.com/